Stay updated with breaking news from Stroke Statistics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
(Family Features) The rise in the number of cardiovascular disease (CVD) deaths in 2020, the first year of the COVID-19 pandemic, represents the largest single-year increase in CVD deaths since 2015 and topped the previous high recorded in 2003.
/PRNewswire/ -- (Family Features) Now, more than three years from the onset of the COVID-19 pandemic, the impacts can be seen more clearly. For example, the...
Injectafer is an intravenous (IV) iron replacement therapy indicated for adult patients with heart failure who have iron deficiency
Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, have announced that the U.S. Food and Drug Administration (FDA) approved INJECTAFER (ferric carboxymaltose injection) for the treatment of iron deficiency in adult patients with heart failure categorized as New York Heart Association class II/III to improve exercise capacity. The company reported that with this approval, INJECTAFER is now the first and only intravenous (IV) iron replacement therapy indicated for adult patients with heart failure who have iron deficiency.
INJECTAFER is now the first and only intravenous iron replacement therapy indicated for adult patients with heart failure who have iron deficiency ... | June 5, 2023